Business● Low5d ago · Nov 2, 2026, 12:03 PM
Axsome Therapeutics GAAP EPS of -$0.25 beats by $0.38, revenue of $259.7M beats by $10.51M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Axsome Therapeutics reported GAAP EPS of -$0.25, surpassing estimates by $0.38, and revenue of $259.7M, exceeding estimates by $10.51M. This indicates better-than-expected financial performance for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business11m agoGas transportation network not responsible for power generation drop – NNPCVanguard NigeriaBusiness16m agoLiverpool FC targets counterfeit pro-Palestinian shirts using altered club crestEuroNews [en]Business1h agoKey deals this week: PANW, META, OGI, CRM and moreSeeking Alpha TechBusiness1h agoInflation, housing, employment, and corporate earnings will dominate the weekly economic agenda in the USClarín